Yves Lapierre - Concepedia

Author

Yves Lapierre

Montreal Neurological Institute and Hospital

Also Known As

J. Girard, M Kremenchutzky, Pierre Duquette, Y D LaPierre, Y Lapierre, Y. LaPierre, Y. Lapierre, YVES LAPIERRE, Yves LaPierre, Yves Lapierre

Publications

6.1K

Citations

H-Index

Concepts

All Affiliations

Montreal Neurological Institute and Hospital McGill University McGill University Health Centre Université de Montréal University of Ottawa

About

Yves Lapierre is an author at Montreal Neurological Institute and Hospital specializing in medicine, multiple sclerosis, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	27	2.9K
2	Health Sciences	5	5	731
3	Social Sciences	4	4	644
4	Public Health	3	3	91
5	Nursing	1	1	30

Yves Lapierre

Publications

5.5K

Citations

H-Index

Page 1

	Year	Citations
The gel test: a new way to detect red cell antigen‐antibody reactions Yves Lapierre, D. Rigal, J. Adam, Transfusion	1990	430
Noradrenergic axon terminals in the cerebral cortex of rat. III. Topometric ultrastructural analysis Laurent Descarries, Kenneth C. Watkins, Yves Lapierre Brain Research NeurophysiologyNeuroanatomySynaptic TransmissionPhysiologyNoradrenergic Axon Terminals	1977	399
The Global Adherence Project (GAP): a multicenter observational study on adherence to disease‐modifying therapies in patients with relapsing‐remitting multiple sclerosis Virginia Devonshire, Yves Lapierre, R. Macdonell, European Journal of Neurology	2010	338
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension Raju Kapoor, Pei‐Ran Ho, Nolan Campbell, The Lancet Neurology Disease ProgressionNeurological DisorderImmunologyClinical TrialsNeurology	2018	327
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial Harold Atkins, Marjorie A. Bowman, David Allan, The Lancet Cell TherapyTransplantationMarrow TransplantationStem Cell MobilizationAggressive Multiple Sclerosis	2016	320
Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. Fred Reimherr, G Chouinard, Cal K. Cohn, PubMed Psychotropic MedicationPsychopharmacologyPharmacotherapyMental HealthSocial Sciences	1990	262
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis Howard L. Weiner, G. A. Mackin, E. John Orav, Neurology	1993	248
Reliability, validity, and applicability of the Quebec User Evaluation of Satisfaction with assistive Technology (QUEST 2.0) for adults with multiple sclerosis Louise Demers, M. Monette, Yves Lapierre, Disability and Rehabilitation	2002	239
The Relationship Between Diffuse Axonal Damage and Fatigue in Multiple Sclerosis Maria Carmela Tartaglia, Sridar Narayanan, Simon J. Francis, Archives of Neurology	2004	206
Type 2 Monocyte and Microglia Differentiation Mediated by Glatiramer Acetate Therapy in Patients with Multiple Sclerosis Igal Ifergan, Jack P. Antel, Rosanne Séguin, The Journal of Immunology Microglia Differentiation MediatedT-regulatory CellImmunologyImmune RegulationImmunologic Mechanism	2004	200

Page 1